It is estimated that one in every eight women will develop breast cancer at some point in their lives. Breast cancer kills an average of 42,000 women every year in the United States.
However, this company is offering hope amidst the tragedy. What if there is a vaccine that significantly lowers each woman’s chance of ever getting breast cancer at all?
One possibility is a new vaccine that has taken decades of research to create at the Cleveland Clinic. It was developed by Anixa Biosciences in San Jose, California, and is driving innovation by targeting triple-negative breast cancer, the disease’s deadliest and most aggressive form.
“This vaccine could potentially eliminate breast cancer,” says Dr. Amit Kumar, Anixa CEO.
The vaccine’s findings from its first trial with 16 women were published on Wednesday, December 6, 2023, with each participant reporting no harmful side effects. There was no resurgence of their cancer either, at least so far.
ALSO READ: Top White House Official Says There’s Almost no Money Left to Help Ukraine Fight Russia
Jennifer Davis is the name of the brave lady who became the first woman in the world to get the vaccine in October 2021.
“This is how we advance medicine. It’s important to be a part of those things,” Davis said. “I am just beyond grateful.”
Davis received a breast cancer diagnosis in September 2018. The diagnosis came six months after her first warning of an abnormality on a routine mammogram and ultrasound.
At the time, her biopsy was nothing to worry about as it was negative for cancer. “I really wanted to believe everything was OK, but I knew something wasn’t right,” Davis said.
At 41 years old, her medical history was free of the mention of cancer. But still, she could feel a lump growing. In the end, she sought a second opinion and a second biopsy.
POLL — Do You Support a Single-Payer Healthcare System (Medicare for All)?
She found out she was living with triple-negative breast cancer. It was terrible news, but she could only think about her family and three children.
“It was very hard to tell them and try and be strong for them,” Davis said. “With triple negative, there is nothing for us to take — no pill or anything to prevent recurrence. The rate is high, and outcomes are poor if it does come back.”
After chemotherapy, a double mastectomy, and radiation, Davis was free of cancer. However, she is not free of the fear that it may return. When she learned of an experimental vaccine trial while receiving her cancer care at the Cleveland Clinic, she volunteered in hopes of finding peace of mind.
ALSO READ: For the First Time Ever, this Group of Fossil Fuel Workers Will Transition Into Renewable Energy
She reports that she has never felt better in the two years since taking the vaccine. The vaccine, pioneered by pre-clinical research led by the late Dr. Vincent Tuohy, has been under observation for over two decades at the Cleveland Clinic.
Many hope the vaccine can get FDA approval for distribution to the public within five years.
You Might Also Like:
Federal Court’s Ruling Favors Texas in Border Battle Against Biden Administration
This Progressive Chicago Teachers Union Boss Has Been Tagged a Hypocrite for Owing Bills
Trump ‘Infuriated’ by Solitary Vote for Him as Speaker of the House
Conservative Dad’s Anti-Woke Calendar Sparks Public Discourse
